Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 24.5.2023Egis Pharmaceuticals PLC (EGI)4483DAssubex 20 mg (tbl flm 28x20 mg (blis.Al/PVC/PE/PVDC))29.5.2023R
 24.5.2023Bayer, spol. s r.o. (BAY-SK-2)83059Clarinase Repetabs (tbl plg 14x5 mg (blis.OPA/Al/PE/LDPE/Al))28.5.2023R
 24.5.2023Baxalta Innovations GmbH (BXA)1229AFlexbumin 200 g/ l (sol inf 1x100 ml (vak PE))23.5.2023R
 23.5.2023Olikla s.r.o. (OLK)0534DTravoprost/timolol Olikla 40 mikrogramov/ml + 5 mg/ml očné roztokové kvapky (int opo 1x2,5 ml (fľ.PP))24.5.2023O
 23.5.2023MEDOCHEMIE Ltd. (MOE)2200BCombogesic 500 mg/150 mg (tbl flm 10x500 mg/150 mg (blis.PVC/Al))1.6.2023U
 23.5.2023MEDOCHEMIE Ltd. (MOE)2202BCombogesic 500 mg/150 mg (tbl flm 20x500 mg/150 mg (blis.PVC/Al))1.6.2023U
 23.5.2023BELUPO, s.r.o. (BLU-SK)20379URUTAL 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))23.5.2023R
 23.5.2023Warszawskie Zaklady Farmaceutyczne Polfa S.A. (WZF)11706BISEPTOL 480 (con inf 10x5 ml)22.5.2023R
 23.5.2023Gedeon Richter Plc. (GDN)12061Haloperidol Decanoat-Richter (sol inj 5x1 ml/50 mg (amp.skl.hnedá))23.5.2023R
 23.5.2023Novartis Slovakia s.r.o. (NVL-2)57866TOBRADEX (int opu 1x5 ml (fľ.PE))24.5.2023R
 23.5.2023Belupo lijekovi i kozmetika d.d. (BEU)9723DBELAKNE COMBI (gel 1x30 g (fľ.PP+pump.PP/LDPE/EVA))23.5.2023U
 23.5.2023ARDEZ Pharma, spol. s r.o. (ARZ)2436DTedez (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))25.5.2023O
 23.5.2023ARDEZ Pharma, spol. s r.o. (ARZ)6424DAladez (tbl flm 90x600 mg (blis.PVC/PVDC/Al))25.5.2023O
 23.5.2023Fresenius Kabi s.r.o. (FRK-CZ-3)4150BGemcitabine Kabi 38 mg/ml infúzny koncentrát (con inf 1x26,3 ml/1000 mg (liek.inj.skl.))31.5.2023O
 23.5.2023Fresenius Kabi s.r.o. (FRK-CZ-3)4202ASmofKabiven (emu inf 6x493 ml (vak Biofin))25.5.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)